JCVI statement: extending the HPV vaccination programme

Evidence and considerations for extending the HPV vaccination programme to adolescent boys: interim statement from JCVI.



This interim statement sets out the Joint Committee on Vaccination and Immunisation’s (JCVI) considerations and advice on the impact of extending the human papillomavirus infection (HPV) vaccination programme to adolescent boys.

The JCVI is consulting with stakeholder groups on its interim findings and once the consultation is completed will publish its final advice.

Published 19 July 2017